Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Corporation (ADPT $13.58)
- $13.58 Cap: $2.04B
- View ADPT Profile
- View Questions on ADPT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adaptive Biotechnologies Corporation (ADPT $13.58)
- $13.58 Cap: $2.04B
- View ADPT Profile
- View Questions on ADPT

Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?

Read Answer Asked by Pierre on June 15, 2023

Adaptive Biotechnologies Corporation (ADPT $13.58)
- $13.58 Cap: $2.04B
- View ADPT Profile
- View Questions on ADPT

Q: Thoughts on Adaptive Biotechnologies Corporation (ADPT)?

Much appreciated,

Read Answer Asked by Jo on March 22, 2021

Amgen Inc. (AMGN $347.80)
- $347.80 P/E (TTM): 24.59X Cap: $187.48B
- View AMGN Profile
- View Questions on AMGN
Johnson & Johnson (JNJ $235.37)
- $235.37 P/E (TTM): 21.54X Cap: $566.91B
- View JNJ Profile
- View Questions on JNJ
Inovio Pharmaceuticals Inc. (INO $1.58)
- $1.58 Cap: $109M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $9.62)
- $9.62 P/E (TTM): 3.78X Cap: $1.56B
- View NVAX Profile
- View Questions on NVAX
Repligen Corporation (RGEN $113.88)
- $113.88 P/E (TTM): 136.76X Cap: $6.41B
- View RGEN Profile
- View Questions on RGEN
Moderna Inc. (MRNA $51.38)
- $51.38 Cap: $20.37B
- View MRNA Profile
- View Questions on MRNA
Adaptive Biotechnologies Corporation (ADPT $13.58)
- $13.58 Cap: $2.04B
- View ADPT Profile
- View Questions on ADPT
Sorrento Therapeutics Inc. (SRNE)
- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Read Answer Asked by Antoine on June 30, 2020